Skip to main content
HR 2325 114th Congress House Health Administrative remedies Department of Health and Human Services Executive agency funding and structure Health technology, devices, supplies Manufacturing Medicare Prescription drugs

To amend title XVIII of the Social Security Act to provide for a pharmaceutical and technology ombudsman under the Medicare program.

Introduced: May 14, 2015 See on congress.gov
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 22, 2015
Referred to the Subcommittee on Health.
May 15, 2015
Referred to the Subcommittee on Health.
May 14, 2015
Introduced in House
May 14, 2015
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
 Plain-English summary Congressional Research Service

This bill amends title XVIII (Medicare) of the Social Security Act to direct the Department of Health and Human Services to provide for a pharmaceutical and technology ombudsman within the Centers for Medicare and Medicaid Services.

What's happening now May 22, 2015

Referred to the Subcommittee on Health.

 Committees of jurisdiction 4